Rare diseases
Investigational molecules
Locations
Study on the Safety and Effectiveness of tolDC for Patients with Relapsing Remitting and Progressive Multiple Sclerosis
BelgiumStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
BelgiumStudy of Patisiran for Patients with Transthyretin Amyloidosis and Heart Disease
BelgiumStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment
BelgiumStudy of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments
BelgiumStudy on ANV600 and Pembrolizumab for Patients with Advanced Solid Tumors
BelgiumStudy of Debio 4228 for Patients with Advanced or Metastatic Prostate Cancer
BelgiumStudy of Resmetirom in Patients with Well-compensated Non-alcoholic Steatohepatitis (NASH) Cirrhosis to Evaluate Effects on Liver Health
BelgiumStudy Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer
BelgiumStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
BelgiumStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
